{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:02:16Z","timestamp":1780048936706,"version":"3.53.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Robert Wood Johnson Foundation Harold Amos Faculty Development Program"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH UL1 TR002645"],"award-info":[{"award-number":["NIH UL1 TR002645"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian National Health and Medical Research Council Investigator Grant","award":["#2008454"],"award-info":[{"award-number":["#2008454"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early detection efforts in melanoma by dermatologists have led to a rising incidence of localized melanoma without a corresponding decrease in late-stage disease or mortality, raising concerns about overdiagnosis. However, little is known about dermatologists\u2019 perspectives on melanoma screening and overdiagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To explore US dermatologists\u2019 views on melanoma screening and overdiagnosis and whether information about overdiagnosis should be communicated to patients and the public.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were collected from semistructured qualitative interviews (n = 15) of US board-certified dermatologists recruited via two email listservs (local and national). Interviews were conducted from January to April 2024. We performed a thematic analysis from qualitative interviews.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Dermatologists [8 woman (53%) and 7 (47%) men, all of whom were non-Hispanic (n = 15) and 10 (67%) of whom were White; mean (SD) age 43.7 (7.6) years] described the benefits of melanoma screening, including early detection, patient education and reassurance. They also reported potential psychological, physical and economic harms of melanoma screening. Many dermatologists felt that the harms of screening did not outweigh the potential benefit. They acknowledged melanoma overdiagnosis as a phenomenon but thought that it mostly happened in other clinician practices due to excessive biopsies, and that a main source of the phenomenon was pathologists who overinterpret histological slides. Dermatologists expressed uncertainty and hesitation about discussing overdiagnosis with patients and the public.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>US dermatologists recognized the benefits and harms of melanoma screening, with many believing that the potential benefits outweighed the harms. While overdiagnosis was acknowledged as a concern at the population level, most dermatologists did not perceive it as a significant issue in their own practices or view themselves as contributors to the problem. Instead, they attributed overdiagnosis primarily to pathologists\u2019 diagnostic decision-making. Furthermore, dermatologists were reluctant to discuss the potential harms of melanoma screening, including overdiagnosis, with patients or the public, especially without the backing of a professional organization. This reluctance has important implications for shared decision-making, informed consent in melanoma screening and efforts to address melanoma overdiagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/skinhd\/vzag033","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:40:35Z","timestamp":1771591235000},"page":"298-305","source":"Crossref","is-referenced-by-count":0,"title":["Perspectives of United States dermatologists on melanoma screening and overdiagnosis: a qualitative\u00a0study"],"prefix":"10.1093","volume":"6","author":[{"given":"Jocelyn","family":"Labrada","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Dell Medical School, University of Texas at Austin , Austin, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srivani","family":"Mandaloju","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dell Medical School, University of Texas at Austin , Austin, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Brandt Ryborg J\u00f8nsson","sequence":"additional","affiliation":[{"name":"Department of People and Technology, Roskilde University , Roskilde ,","place":["Denmark"]},{"name":"Department of Community Health, Research Unit for General Practice, The Arctic University of Norway , Troms\u00f8 ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Brandt Brodersen","sequence":"additional","affiliation":[{"name":"Centre of Cancer and Organ Diseases, Copenhagen University Hospital , Copenhagen","place":[", Denmark"]},{"name":"Research Unit for General Practice, Department of Community Medicine, Faculty of Health Sciences, UiT \u2013 The Arctic University of Norway , Troms\u00f8 ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5331-6370","authenticated-orcid":false,"given":"Anne\u00a0E","family":"Cust","sequence":"additional","affiliation":[{"name":"The Daffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW , Sydney,\u00a0NSW ,","place":["Australia"]},{"name":"Melanoma Institute Australia, The University of Sydney , Sydney, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Tsevat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dell Medical School, University of Texas at Austin , Austin, TX ,","place":["USA"]},{"name":"Center for Research to Advance Community Health and Division of General Internal Medicine, Department of Medicine, Long School of Medicine, University of Texas Health Science Center at San Antonio , San Antonio, TX ,","place":["USA"]},{"name":"Department of Population Health, Dell Medical School, The University of Texas at Austin , Austin, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P","family":"Pignone","sequence":"additional","affiliation":[{"name":"Department of Population Health, Dell Medical School, The University of Texas at Austin , Austin, TX ,","place":["USA"]},{"name":"Department of Medicine, Duke University School of Medicine , Durham, NC ,","place":["USA"]},{"name":"Duke Cancer Institute, Duke University School of Medicine , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adewole S","family":"Adamson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dell Medical School, University of Texas at Austin , Austin, TX ,","place":["USA"]},{"name":"Division of Dermatology, Dell Medical School, University of Texas at Austin , Austin, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"2026052905172954900_vzag033-B1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1056\/NEJMsb2019760","article-title":"The rapid rise in cutaneous melanoma diagnoses","volume":"384","author":"Welch","year":"2021","journal-title":"N Engl J Med"},{"key":"2026052905172954900_vzag033-B2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jamadermatol.2023.1494","article-title":"Risk of mortality after a diagnosis of melanoma in situ","volume":"159","author":"Patel","year":"2023","journal-title":"JAMA Dermatol"},{"key":"2026052905172954900_vzag033-B3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/cncr.34490","article-title":"Prognostic modeling of cutaneous melanoma stage I patients using cancer registry data identifies subsets with very-low melanoma mortality","volume":"129","author":"Eguchi","year":"2023","journal-title":"Cancer"},{"key":"2026052905172954900_vzag033-B4","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1200\/JCO.2012.47.3728","article-title":"Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry","volume":"31","author":"Geller","year":"2013","journal-title":"J Clin Oncol"},{"key":"2026052905172954900_vzag033-B5","first-page":"CD012352","article-title":"Screening for reducing morbidity and mortality in malignant melanoma","volume":"6","author":"Johansson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2026052905172954900_vzag033-B6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmjebm-2023-112341","article-title":"Overdiagnosis in malignant melanoma: a scoping review","volume":"29","author":"Bjorch","year":"2024","journal-title":"BMJ Evid Based Med"},{"key":"2026052905172954900_vzag033-B7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/bmjebm-2023-112460","article-title":"Ecological study estimating melanoma overdiagnosis in the USA using the lifetime risk method","volume":"29","author":"Adamson","year":"2024","journal-title":"BMJ Evid Based Med"},{"key":"2026052905172954900_vzag033-B8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/jamadermatol.2022.0139","article-title":"Estimating overdiagnosis of melanoma using trends among Black and White patients in the US","volume":"158","author":"Adamson","year":"2022","journal-title":"JAMA Dermatol"},{"key":"2026052905172954900_vzag033-B9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/bjd.21649","article-title":"The effect of screening on melanoma incidence and biopsy rates","volume":"187","author":"Whiteman","year":"2022","journal-title":"Br J Dermatol"},{"key":"2026052905172954900_vzag033-B10","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/jama.2023.4342","article-title":"Screening for skin cancer: US preventive services task force recommendation statement","volume":"329","author":"US Preventive Services Task Force","year":"2023","journal-title":"JAMA"},{"key":"2026052905172954900_vzag033-B11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jamadermatol.2023.0706","article-title":"The USPSTF I statement on skin cancer screening-not a disappointment but an opportunity","volume":"159","author":"Adamson","year":"2023","journal-title":"JAMA Dermatol"},{"key":"2026052905172954900_vzag033-B12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaad.2016.09.017","article-title":"Frequency of total body skin examinations among US dermatologists","volume":"76","author":"Stevenson","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2026052905172954900_vzag033-B13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jid.2023.09.003","article-title":"Prevalence of total body skin examinations among dermatology encounters in Medicare data: a retrospective cohort study","volume":"144","author":"Nowakowska","year":"2024","journal-title":"J Invest Dermatol"},{"key":"2026052905172954900_vzag033-B14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"key":"2026052905172954900_vzag033-B15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14780887.2013.801543","article-title":"Sampling in interview-based qualitative research: a theoretical and practical guide","volume":"11","author":"Robinson","year":"2014","journal-title":"Qual Res Psychol"},{"key":"2026052905172954900_vzag033-B16","first-page":"277","volume-title":"The Oxford Handbook of Qualitative Research","author":"Brinkmann","year":"2014"},{"key":"2026052905172954900_vzag033-B17","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/1475-6773.12275","article-title":"Using grounded theory method to capture and analyze health care experiences","volume":"50","author":"Foley","year":"2015","journal-title":"Health Serv Res"},{"key":"2026052905172954900_vzag033-B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2022.06.1191","article-title":"Dermatology workforce in the United States \u2013 part I: overview, transformations, and implications","volume":"89","author":"Gronbeck","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"2026052905172954900_vzag033-B19","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jamainternmed.2013.10363","article-title":"Less is more: overdiagnosis and overtreatment: evaluation of what physicians tell their patients about screening harms","volume":"173","author":"Wegwarth","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2026052905172954900_vzag033-B20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.amepre.2014.04.011","article-title":"Lack of shared decision making in cancer screening discussions: results from a national survey","volume":"47","author":"Hoffman","year":"2014","journal-title":"Am J Prev Med"},{"key":"2026052905172954900_vzag033-B21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/13698575.2020.1778645","article-title":"The perception gap: how the benefits and harms of cervical cancer screening are understood in information material focusing on informed choice","volume":"22","author":"Byskov Petersen","year":"2020","journal-title":"Health Risk Soc"},{"key":"2026052905172954900_vzag033-B22","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/healthcare11091230","article-title":"Questioning \u2018informed choice\u2019 in medical screening: the role of neoliberal rhetoric, culture, and social context","volume":"11","author":"Gram","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"2026052905172954900_vzag033-B23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jamadermatol.2022.0489","article-title":"Dermatopathologist perceptions of overdiagnosis of melanocytic skin lesions and association with diagnostic behaviors","volume":"158","author":"Kerr","year":"2022","journal-title":"JAMA Dermatol"},{"key":"2026052905172954900_vzag033-B24","volume-title":"The Actor and the Observer: Divergent Perceptions of the Causes of Behavior","author":"Jones","year":"1971"},{"key":"2026052905172954900_vzag033-B25","doi-asserted-by":"crossref","first-page":"e0315247","DOI":"10.1371\/journal.pone.0315247","article-title":"Do health professionals know about overdiagnosis in screening, and how are they dealing with it? A mixed-methods systematic scoping review","volume":"20","author":"Piessens","year":"2025","journal-title":"PLOS ONE"},{"key":"2026052905172954900_vzag033-B26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamainternmed.2014.6016","article-title":"Patients\u2019 expectations of the benefits and harms of treatments, screening, and tests: a systematic review","volume":"175","author":"Hoffmann","year":"2015","journal-title":"JAMA Intern Med"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/3\/298\/68121579\/vzag033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/3\/298\/68121579\/vzag033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:17:36Z","timestamp":1780046256000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/6\/3\/298\/8659874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4,21]]},"published-print":{"date-parts":[[2026,5,29]]}},"URL":"https:\/\/doi.org\/10.1093\/skinhd\/vzag033","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,21]]}}}